Skip to main content
. 2022 May 23;25(6):104442. doi: 10.1016/j.isci.2022.104442

Figure 2.

Figure 2

Transgenic prostacyclin does not require Fzd9 expression for preventive effects in the mouse lung

(A) Change in weights of mice in the urethane model.

(B) Average adenoma number per mouse in the urethane exposed groups.

(C) Diameter of adenomas in urethane exposed groups. WT, wild type; PgisTg, prostacyclin synthase transgenic; PgisTg x Fzd9−/− prostacyclin synthase transgenic with Fzd9 knockout. Data are represented as mean ± SEM. A one-way ANOVA with Tukey’s post-hoc test was used to measure significance. ∗p < 0.05.